Santarus

  www.santarus.com
  www.santarus.com

Santarus Reviews

13 Reviews
3.6
13 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
Santarus President, CEO, and Director Gerald T. Proehl
Gerald T. Proehl
9 Ratings
  1.  

    its ok

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    • Career Opportunities
    Former Employee - Anonymous Employee
    Former Employee - Anonymous Employee

    I worked at Santarus full-time (more than an year)

    Pros

    small pond, you can really achieve something here if you can save them

    Cons

    never sure who is running the show. The owners do not want to do the hard work needed to make it successful.

    Doesn't Recommend
    No opinion of CEO

Santarus Interviews

Interview Experience

Interview Experience

100%
0%
0%

Getting an Interview

Getting an Interview

50%
50%

Interview Difficulty

2.5
Average

Interview Difficulty

Hard

Average

Easy
  1.  

    Specialty Sales Professional Interview

    Anonymous Interview Candidate
    Anonymous Interview Candidate
    Application Details

    I applied through an employee referral. The process took 2 weeksinterviewed at Santarus.

    Interview Details

    Phone interview with local inVentiv recruiter, phone interview with hiring District Sales Manager, face to face interview with Regional Sales Director, hiring District Sales Manager, and inVentiv ERM.

    Interview Questions
    Accepted Offer
    Positive Experience
    Average Interview

Santarus Awards and Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Website www.santarus.com
Headquarters San Diego, CA
Size 150 to 499 Employees
Founded 1996
Type Company - Public
Industry Biotech & Pharmaceuticals
Revenue ₹5 to ₹10 billion (INR) per year

Santarus is a bit controlling, but in this case it's okay. Santarus' flagship drug Glumetza improves glycemic control for type 2 diabetes patients and is marketed through a partnership with Depomed. It markets a similar drug, Cycloset, also to improve glycemic control for type 2 diabetes, through a distribution and license agreement with S2 Therapeutics and Veroscience. Santarus' lead product used to be Zegerid, a modified version of omeprazole, the proton pump inhibitor found in AstraZeneca's best-selling Prilosec for heartburn. But when Zegerid's patent ran out and its... More

Work at Santarus? Share Your Experiences

Santarus

 
Click to Rate
or